Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
Apr 22, 16:00
Sinovac Biotech Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | 481.10M |
| September 30, 2020 | 14.10M |
| June 30, 2020 | 2.356M |
| March 31, 2020 | -18.24M |
| December 31, 2019 | 26.45M |
| September 30, 2019 | 11.61M |
| June 30, 2019 | 9.72M |
| March 31, 2019 | -8.703M |
| December 31, 2018 | 7.694M |
| September 30, 2018 | 13.15M |
| June 30, 2018 | -7.939M |
| March 31, 2018 | -4.964M |
| December 31, 2016 | 1.564M |
| September 30, 2016 | 0.098M |
| June 30, 2016 | -6.021M |
| March 31, 2016 | -9.543M |
| December 31, 2015 | 14.83M |
| September 30, 2015 | -2.849M |
| June 30, 2015 | 0.424M |
| March 31, 2015 | -8.195M |
| December 31, 2014 | 6.021M |
| September 30, 2014 | -4.735M |
| June 30, 2014 | -5.615M |
| March 31, 2014 | -5.798M |
| Date | Value |
|---|---|
| December 31, 2013 | 20.26M |
| September 30, 2013 | -5.378M |
| June 30, 2013 | -3.736M |
| March 31, 2013 | -5.568M |
| December 31, 2012 | 8.183M |
| September 30, 2012 | -6.260M |
| June 30, 2012 | -6.309M |
| March 31, 2012 | -11.87M |
| December 31, 2011 | 16.58M |
| September 30, 2011 | 1.634M |
| June 30, 2011 | 3.413M |
| March 31, 2011 | -7.690M |
| December 31, 2010 | 11.79M |
| September 30, 2010 | -9.053M |
| June 30, 2010 | -6.868M |
| March 31, 2010 | -10.15M |
| December 31, 2009 | 39.65M |
| September 30, 2009 | 7.457M |
| June 30, 2009 | 8.136M |
| March 31, 2009 | -6.832M |
| December 31, 2008 | 10.30M |
| September 30, 2008 | 3.306M |
| June 30, 2008 | -1.697M |
| March 31, 2008 | -1.402M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-18.24M
Minimum
Mar 2020
481.10M
Maximum
Dec 2020
75.30M
Average
11.61M
Median
Sep 2019
Cash from Operations (Quarterly) Benchmarks
| CASI Pharmaceuticals Inc | -- |
| Zai Lab Ltd | -14.92M |
| I-MAB | -- |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Adagene Inc | -- |